Interestingly, recent studies suggest that glioblastoma cells retain functional circadian networks, and therapeutic responses, such as to TMZ, may depend on the timing of drug administration in relation to clock gene expression [5,13,14,15]. The gene discussed is CLOCK; the disease is glioblastoma.